Open Government Portal

Found 10 records similar to Backgrounder: Government of Canada invests millions into mental health and distress centres

Federal

The COVID-19 pandemic has affected individuals, families, and communities in several ways. Almost 7 out of 10 Canadians reported being negatively impacted by COVID-19. Almost 2 out of 5 Canadians reported some level of distress in the past month. With social distancing and repeated lockdown measures, feelings of isolation and loneliness can increase levels of anxiety and depression.

Last Updated: Jun. 26, 2021
Date Published: May 31, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Anxiety, depression, the COVID-19 pandemic, distress, social distancing, lockdown, isolation, loneliness
Federal

PTSD is a mental disorder that can happen after exposure to potentially psychologically traumatic events (e.g., actual or threatened death, natural disasters, violence). Symptoms of PTSD include recurring and distressing memories, avoiding reminders of the event(s), and disturbed sleep. The COVID-19 pandemic has impacted individuals, families, and communities in many ways. Stressors from the pandemic may increase the number of Canadians experiencing symptoms of PTSD.

Last Updated: Jun. 26, 2021
Date Published: Jun. 2, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Posttraumatic stress disorder, mental health, mental disorder, symptoms, COVID-19 pandemic
Federal

COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.

Last Updated: May 28, 2021
Date Published: May 7, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Covid-19, pandemic, covid vaccine, Pfizer covid vaccine, Pfizer COVID-19 vaccine, Moderna covid vaccine, Moderna COVID-19 vaccine, AstraZeneca covid vaccine, AstraZeneca COVID-19 vaccine
Federal

COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical devices used to diagnose, treat or prevent COVID-19.

Last Updated: Apr. 7, 2020
Date Published: Apr. 2, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, COVID-19 pandemic, importation and sale of medical devices, diagnose, treat or prevent COVID-19, list of COVID-19 Diagnostic Device.
Federal

This page presents detailed information on Canada's whole-of-government actions to respond to the COVID-19 outbreak.

Last Updated: Sep. 24, 2021
Date Published: May 9, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, outbreak, Canada’s response, COVID-19, pandemic, COVID, coronavirus
Federal

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.

Last Updated: Apr. 7, 2020
Date Published: Apr. 3, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 outbreak, pandemic, vaccine for COVID-19, health product submissions and applications
Federal

Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.

Last Updated: Jul. 27, 2021
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, pandemic, drugs, medications, vaccines, market authorization, licensing, importing or selling
Federal

What you, and what communities can do to lower the spread of COVID-19 in settings including social services, workplaces, outdoors, community, religious, transport and remote and Indigenous communities.

Last Updated: Sep. 24, 2021
Date Published: Jun. 12, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Coronavirus, COVID-19, pandemic, measures, to reduce, COVID-19, COVID
Federal

This primer is intended to support health care providers in better understanding and addressing COVID-19 vaccine hesitancy, in their practice and beyond.

Last Updated: May 28, 2021
Date Published: Apr. 28, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, pandemic, covid vaccine, COVID-19 vaccine hesitancy
Federal

Several different types of treatments for COVID-19 have been developed. Examples include drugs that reduce or stop the virus from multiplying in human cells and drugs that treat the symptoms of COVID-19.

Last Updated: Jun. 30, 2021
Date Published: Apr. 8, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, coronavirus, market authorization, COVID-19 Treatments, treatments, drugs, reduce or stop the virus from multiplying, treat the symptoms of COVID-19
Date modified: